AEMCOLO 194 mg Delayed Release Oral Tablet
RxNorm 2106362
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2106362 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: AEMCOLO 194 mg Delayed Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
AEMCOLO 194 mg Delayed Release Oral Tablet
(Atom ID: 10783162)
SYPrescribable
Synonym (SY):
Aemcolo 194 mg Delayed Release Oral Tablet
(Atom ID: 10783163)
SBDPrescribable
Semantic Branded Drug (SBD):
Rifamycin SV 194 mg Delayed Release Oral Tablet [Aemcolo]
(Atom ID: 10783161)
Patient Education
Rifamycin
Rifamycin is used to treat of travelers' diarrhea caused by certain bacteria. Rifamycin is in a class of medications called antibiotics. It works by stopping the growth of the bacteria that cause diarrhea. Antibiotics such as rifamycin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
[Learn More]
* Please review the disclaimer below.